Legend Biotech (LEGN) Shares Issued (2020 - 2025)

Legend Biotech has reported Shares Issued for 6 years, with the latest figure at $1.3 million in Q3 2025.

• For the quarter ending Q3 2025, Shares Issued fell 76.48% year-over-year to $1.3 million; the trailing twelve-month figure through Sep 2025 stood at $3.6 million (down 63.1% YoY), and the FY2024 full-year result was $9.7 million, down 17.77% from the prior year.
• Shares Issued for Q3 2025 stood at $1.3 million, up from $273000.0 in the prior quarter.
• The five-year high for Shares Issued was $8.1 million in Q2 2023, with the low at $273000.0 in Q2 2025.
• Historically, Shares Issued has averaged $1.8 million across 5 years, with a median of $1.1 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Issued jumped 667.48% — and 2025, when it sank 87.09%.
• Legend Biotech's Shares Issued stood at $2.1 million in 2021, then sank by 70.72% to $624000.0 in 2022, then retreated by 0.48% to $621000.0 in 2023, then dropped by 2.9% to $603000.0 in 2024, then jumped by 110.95% to $1.3 million in 2025.
• The last three Shares Issued figures came in at $1.3 million (Q3 2025), $273000.0 (Q2 2025), and $1.4 million (Q1 2025), per Business Quant data.